Khunkit, P.; Siripaitoon, P.; Lertsrisatit, Y.; Watthanapaisal, D.; Kositpantawong, N.; Kanchanasuwan, S.; Cheh-oh, N.; Chittrakarn, S.; Jaroenmark, T.; Poonchuay, N.;
et al. Impact of Empirical Antimicrobial Treatment on Patients with Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia. Antibiotics 2024, 13, 729.
https://doi.org/10.3390/antibiotics13080729
AMA Style
Khunkit P, Siripaitoon P, Lertsrisatit Y, Watthanapaisal D, Kositpantawong N, Kanchanasuwan S, Cheh-oh N, Chittrakarn S, Jaroenmark T, Poonchuay N,
et al. Impact of Empirical Antimicrobial Treatment on Patients with Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia. Antibiotics. 2024; 13(8):729.
https://doi.org/10.3390/antibiotics13080729
Chicago/Turabian Style
Khunkit, Pirawan, Pisud Siripaitoon, Yongyut Lertsrisatit, Dissaya Watthanapaisal, Narongdet Kositpantawong, Siripen Kanchanasuwan, Nadia Cheh-oh, Sorawit Chittrakarn, Tanapat Jaroenmark, Natnicha Poonchuay,
and et al. 2024. "Impact of Empirical Antimicrobial Treatment on Patients with Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia" Antibiotics 13, no. 8: 729.
https://doi.org/10.3390/antibiotics13080729
APA Style
Khunkit, P., Siripaitoon, P., Lertsrisatit, Y., Watthanapaisal, D., Kositpantawong, N., Kanchanasuwan, S., Cheh-oh, N., Chittrakarn, S., Jaroenmark, T., Poonchuay, N., & Chusri, S.
(2024). Impact of Empirical Antimicrobial Treatment on Patients with Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia. Antibiotics, 13(8), 729.
https://doi.org/10.3390/antibiotics13080729
